Glofitamab,Obinutuzumab,Tocilizumab
roche
['glofitamab', 'mantle,(-dismantle)', 'obinu', 'lymphoma']
#ash22 updates in #mcl: #glofitamab monotherapy demonstrates high and durable complete response rates in patients with r/r #mcl || for more aggrego coverage of the latest mcl news from #ash22 visit: #medtwitter #onctwitter #hematology #lymphoma 
Your source for the latest in oncology news.